
Nvidia leads Nasdaq to fresh record high
The Nasdaq hits a new high on the back of a stellar Nvidia performance, with investors predicting an out-sized impact from the chip titan's earnings. JP Morgan CEO Jamie Dimon suggests he will quit...

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SAN MATEO, Calif. , May 20, 2024 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative thera...

The 3 Most Undervalued Nasdaq 100 Stocks to Buy in May 2024
The Nasdaq 100 presents a compelling investment opportunity for several reasons. Firstly, it features a roster of top global brands, encompassing influential companies that dominate various sectors...

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Achilles ADSs will continue to trade on the Nasdaq Global Select Market at this time, and the Company's operations are not affected by the receipt of the Notice Achilles ADSs will continue to trade...

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for r...

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant's Board ...

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies...

Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq...
NEW YORK , May 16, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for ...

Society Pass Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
SINGAPORE, May 16, 2024 (GLOBE NEWSWIRE) -- Society Pass Inc. (NASDAQ: SOPA) (“SoPa” or the “Company”), a leading e-commerce ecosystem in Southeast Asia (“SEA”), announced a formal notification fro...

Assure Announces it will Remain Listed on the Nasdaq Capital Market Pursuant to Nasdaq Panel Decision
DENVER, May 16, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, annou...

Tech Stock Ready For A Bounce
The shares of global technology company Nasdaq (NDAQ) have been choppy the past few months, with firm support at the $58 level. Today's 1.7% rise has NDAQ adding to its 5.8% year-to-date gain, and ...

Nasdaq: Operating Leverage Embedded Given Revenue Mix; Multiple Expansion Is Warranted
Following the acquisition of Adenza in 2023, Nasdaq's operating margins are set for significant expansion. Deleveraging likely to occur ahead of schedule, which could lead to increased capital retu...

Nasdaq's (NDAQ) Q1 Earnings Miss, Revenues Top, Dividend Raised
Nasdaq's (NDAQ) first-quarter results reflect lower Market Services net revenues and higher expenses. Listings, too, dropped in the reported quarter.

Nasdaq (NDAQ) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Stree...

Nasdaq (NDAQ) Misses Q1 Earnings Estimates
Nasdaq (NDAQ) came out with quarterly earnings of $0.63 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.69 per share a year ago.
Related Companies